Prevention of chronic rejection and puromycin-induced glomerulosclerosis in rats by gamma-lactone, an inhibitor of macrophage-effector activation.
Ishibashi
M
M
Service d'Urologie et Chirurgie de la Transplantation, Hopital Edouard Herriot, Lyon, France.
Azuma
H
H
Margonari
J
J
Revillard
J P
JP
Martin
X
X
Dubernard
J M
JM
Tilney
N L
NL
D000818:Animals; D005663:Furans / Q000494:pharmacology*; D005921:Glomerulonephritis / Q000139:chemically induced / Q000517:prevention & control*; D006084:Graft Rejection / Q000473:pathology / Q000517:prevention & control*; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D016030:Kidney Transplantation / Q000276:immunology / Q000473:pathology / Q000502:physiology*; D008262:Macrophage Activation; D008297:Male; D011507:Proteinuria; D011691:Puromycin / Q000633:toxicity*; D051381:Rats; D011916:Rats, Inbred F344; D011917:Rats, Inbred Lew; D017207:Rats, Sprague-Dawley; D014184:Transplantation, Homologous
D005663:Furans; C092304:IT 174; D007166:Immunosuppressive Agents; D011691:Puromycin